What is LOPJLB’s current signal on SBFM?

LOPJLB’s latest quantitative signal on Sunshine Biopharma, Inc. (SBFM) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is SBFM in?

Sunshine Biopharma, Inc. (SBFM) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Sunshine Biopharma, Inc. (SBFM) do?

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, l…

Sunshine Biopharma, Inc. (SBFM)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

$0.24-20.00%Close

BUYCRISIS · day 32

[SCORES & PROFILE]

FUND: 11
VALUE: 21
GROWTH: 32
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-14.5%

REV YoY-

ROE-24.2%

EPS YoY-

ROA-17.3%

GROSS

-15

NET

-17

[VALUATION]

P/E TTM-0.02

P/E FWD-

SECTOR PE20.34

INDUSTRY PE19.31

P/B0.01

P/FCF-

EV/EBITDA2.38

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E2.46

ALTMAN Z-

CURR RATIO5.46

ND/EBITDA-

BETA1.35

FAQ

What is LOPJLB’s current signal on SBFM?: LOPJLB’s latest quantitative signal on Sunshine Biopharma, Inc. (SBFM) is BUY in a CRISIS regime. Signals are updated daily.
What market regime is SBFM in?: Sunshine Biopharma, Inc. (SBFM) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Sunshine Biopharma, Inc. (SBFM) do?: Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, l…

Sunshine Biopharma, Inc. (SBFM)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ